Clinical Trial

A Phase II Study of SHR-8068 Injection in Combination With Anti-tumor Therapies in Colorectal Cancer

Active, Not Recruiting Phase 2
View on ClinicalTrials.gov →
Summary
The study is being conducted to evaluate the safety, tolerability and efficacy of SHR-8068 injection in combination with anti-tumor therapies in subjects with colorectal cancer.
Protocol Amendment History 2 changes
critical Enrollment closed, study ongoing 2026-08-12
notable Enrollment reduced: 200 -> 103 participants 2026-08-12
Trial Details
NCT Number NCT07071714
Lead Sponsor Suzhou Suncadia Biopharmaceuticals Co., Ltd.
Conditions Colorectal Cancer
Enrollment 103 participants
Start Date 2025-07-22
Primary Completion 2031-10 (estimated)
Study Completion 2031-10 (estimated)
Updated on ClinicalTrials.gov 2026-08-11